Insulin-like growth factor type 2 (IGF2) receptor (IGF2R) recognizes mannose 6-phosphate-containing molecules and IGF2 and plays an important role in many pathophysiological processes, including gut mucosal adaptation. However, the mechanisms that control cellular IGF2R abundance are poorly known. MicroRNAs (miRNAs) and RNA-binding proteins (RBPs) critically regulate gene expression programs in mammalian cells by modulating the stability and translation of target mRNAs. Here we report that miRNA 195 (miR-195) and RBP CUG-binding protein 1 (CUGBP1) jointly regulate IGF2R expression at the posttranscriptional level in intestinal epithelial cells. Both miR-195 and CUGBP1 interacted with the 3= untranslated region (3=-UTR) of Igf2r mRNA, and the association of CUGBP1 with Igf2r mRNA enhanced miR-195 binding to Igf2r mRNA. Ectopically expressed CUGBP1 and miR-195 repressed IGF2R translation cooperatively without altering the stability of Igf2r mRNA. Importantly, the miR-195-and CUGBP1-repressed levels of cellular IGF2R led to a disruption in the structure of the trans-Golgi network. These findings indicate that IGF2R expression is controlled posttranscriptionally by two factors that associate with Igf2r mRNA and suggest that miR-195 and CUGBP1 dampen IGF signaling by inhibiting IGF2R translation.KEYWORDS insulin superfamily, posttranscriptional regulation, trans-Golgi network, intestinal epithelial cells, RNA-binding proteins, noncoding RNAs M ucosal regeneration/adaptation is an essential process in gut homeostasis and tightly regulated by numerous factors, including insulin-like growth factor type 1 (IGF1) and IGF2 (1, 2). Two structurally distinct types of receptors, the IGF1 receptor (IGF1R) and IGF2R, specifically interact with IGF1 and IGF2 as ligands and regulate diverse biological functions such as cell proliferation, differentiation, and apoptosis (3, 4). Like the insulin receptor, IGF1R is a heterotetrameric transmembrane receptor tyrosine kinase, and its activation results in autophosphorylation of tyrosine residues in the intracellular -subunits, thus initiating the phosphatidylinositol 3-kinase (PI3) kinase/AKT and/or mitogen-activated protein (MAP) kinase signaling cascade (5). In contrast, IGF2R is a single-transmembrane-domain protein and binds IGF2 with greater affinity than IGF1, although it does not accept insulin as a ligand (4, 6). IGF2R also recognizes, via distinct sites, mannose-6-phosphate (M6P)-containing molecules and can therefore associate with other growth factors and cytokines (4). The majority of IGF2R is localized in the trans-Golgi network (TGN) and endosomal compartments and, to a lesser extent, on the cell surface (6). A subpopulation of the IGF2R on the plasma membrane regulates IGF2 internalization and various M6P-containing ligands for their